Investor Lawsuit Deadlines Loom

Investors are being reminded of approaching deadlines to lead securities class action lawsuits against several companies. Key deadlines include March 2 for agilon health (AGL) and Helen of Troy (HELE), and March 9 for Varonis Systems (VRNS).

The role of a "lead plaintiff" is a crucial one in securities class action lawsuits; this investor acts as a representative for the entire group of affected shareholders. The court appoints the lead plaintiff, typically the investor who has the largest financial interest in the outcome of the case. This individual or entity then directs the course of the litigation, including selecting the law firm that will represent the class. The lawsuit against agilon health alleges that the company misled investors about its medical costs and the effectiveness of its business model. The complaint claims that agilon did not disclose rising medical costs due to higher healthcare use by Medicare Advantage patients. Following the revelation of these issues and a leadership change, agilon's stock price fell by 51.5% to $0.88 per share on August 5, 2025. In the case of Helen of Troy, the company's stock price dropped by approximately 25% to $20.71 per share on October 9, 2025. This decline followed the release of the company's second-quarter financial results for fiscal year 2026, which showed an 8.9% year-over-year decrease in consolidated net sales and a significant GAAP diluted loss per share of $13.44. The lawsuit involving Varonis Systems claims the company made misleading statements about its ability to convert existing on-premise customers to its Software-as-a-Service (SaaS) platform. On October 28, 2025, Varonis announced third-quarter results that fell short of projections and lowered its full-year guidance. This news caused the company's stock to fall by nearly 49%.

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.